UNASSIGNED: Patients with infra-renal AAA treated by elective and emergency EVAR between March 2014 and November 2020 were retrospectively identified. Demographic data, risk factors, American Society of Anesthesiologists (ASA) score, systemic complications, stent-graft related complications, surgical site complications, 30-day mortality, late EVAR related mortality, estimated blood loss, intensive care unit (ICU) length of stay (LOS), hospital LOS and follow-up durations were collected and analyzed.
UNASSIGNED: A total of 43 patients underwent EVAR during the period of study. There were 42 males (97.7%) and 1 female (2.3%). The mean age was 68.8 ± 6.2 years. Elective EVAR was performed in 36 (83.7%) and emergency EVAR in 7 (16.3%). Technical success was achieved in 42 patients (100%) with no conversion to OAR. Stent-graft related complications were (21.0%) endoleaks, (2.3%) graft limb occlusion, (0%) graft infection, and (2.3%) rupture-EVAR. Systemic complications were (2.3%) myocardial infarction (MI), (2.3%) stroke, (2.3%) spinal cord injury (SCI), (2.3%) respiratory failure, (19.0%) wound complications, and (2.3%) acute lower limb ischemia (ALI). The 30-day mortality was (2.3%) due to perioperative MI and the late graft related mortality was (2.3%) due to rupture-EVAR.
UNASSIGNED: EVAR showed a high technical success rate with no conversion to OAR. The most common complications were type II and type I endoleaks followed by graft limb occlusion. The 30-day mortality was 2.3% due to perioperative MI. Only one late stent-graft related mortality was registered due to rupture-EVAR.
■对2014年3月至2020年11月期间接受择期和急诊EVAR治疗的肾下AAA患者进行回顾性鉴定。人口统计数据,危险因素,美国麻醉医师协会(ASA)评分,全身性并发症,支架移植物相关并发症,手术部位并发症,30天死亡率,晚期EVAR相关死亡率,估计失血量,重症监护病房(ICU)住院时间(LOS),收集并分析医院LOS和随访时间.
■在研究期间共有43名患者接受了EVAR。男性42例(97.7%),女性1例(2.3%)。平均年龄为68.8±6.2岁。选择性EVAR36例(83.7%),急诊EVAR7例(16.3%)。42例患者(100%)获得了技术成功,没有转换为OAR。支架移植物相关并发症为内漏(21.0%),(2.3%)移植肢体闭塞,(0%)移植物感染,和(2.3%)破裂-EVAR。全身并发症(2.3%)心肌梗死(MI),(2.3%)中风,(2.3%)脊髓损伤(SCI),(2.3%)呼吸衰竭,(19.0%)伤口并发症,(2.3%)急性下肢缺血(ALI)。围手术期MI导致30天死亡率(2.3%),破裂EVAR导致晚期移植物相关死亡率(2.3%)。
■EVAR显示出很高的技术成功率,没有转换为OAR。最常见的并发症是II型和I型内漏,其次是移植肢闭塞。围手术期MI导致30天死亡率为2.3%。由于破裂-EVAR,仅记录了一例晚期支架移植物相关死亡。